Ada Yonath

Ada E. Yonath
Born	Ada Lifshitz 6/22/1939
Birthplace	Jerusalem, Mandatory Palestine
Nationality	Israeli
Occupation	Crystallographer, professor
Employer	Weizmann Institute of Science
Known for	Pioneering work on ribosome structure; cryo bio-crystallography
Education	Ph.D. in X-ray crystallography (Weizmann Institute of Science)
Awards	Nobel Prize in Chemistry (2009), Israel Prize (2002), Wolf Prize in Chemistry (2007)
Website	http://www.weizmann.ac.il/sb/faculty_pages/Yonath/home.html

Ada E. Yonath (עדה יונת (Hebrew: עדה יונת); born Ada Lifshitz, 22 June 1939) is an Israeli crystallographer and Nobel laureate best known for her research into the three-dimensional structure of the ribosome, the molecular machine within cells that translates genetic information into proteins. Born in Jerusalem during the British Mandate for Palestine, Yonath took on what many of her contemporaries saw as an impossible scientific challenge: mapping the atomic structure of one of the largest and most complex biological assemblies ever studied by X-ray crystallography. In 2009, she won the Nobel Prize in Chemistry, shared with Venkatraman Ramakrishnan and Thomas A. Steitz, for studies on the structure and function of the ribosome. That achievement made her the first Israeli woman to win a Nobel Prize, the first woman from the Middle East to receive a Nobel in the sciences, and the first woman in 45 years to win the Nobel Prize for Chemistry. She directs the Helen and Milton A. Kimmelman Center for Biomolecular Structure and Assembly at the Weizmann Institute of Science.

Early Life

Ada Lifshitz was born on 22 June 1939 in Jerusalem, in what was then Mandatory Palestine. Her early years were marked by modest circumstances. Her parents were Zionist immigrants from Poland, and her father served as a rabbi; the family made their home in Jerusalem's Geula neighborhood, where financial hardship was a constant struggle.

Economic hardship didn't dampen her intellectual curiosity about nature. In 2018, she recalled that as a child she was deeply inquisitive, though she'd say, "I never wanted to be a scientist." Still, her natural drive toward experimentation showed itself early. As a child, she famously tried to measure her apartment's ceiling height by stacking furniture, an effort that ended with a fall and a broken arm. That incident, as it turned out, would become a perfect symbol of her later determination.

Her father died when she was eleven. Loss compounded the family's money troubles. They moved to Tel Aviv afterward, and she continued her schooling there. Despite the hardship, she excelled academically and grew increasingly interested in science during secondary school. Tel Aviv also offered better educational opportunities, which she seized to pursue her scientific interests.

Education

She attended high school in Tel Aviv and then enrolled at the Hebrew University of Jerusalem to study chemistry, later earning a master's degree in biochemistry. Doctoral studies came next at the Weizmann Institute of Science in Rehovot, Israel, where she completed her Ph.D. in X-ray crystallography under Wolfie Traub. Her doctoral research introduced her to crystallography techniques that would define her life's work.

After earning her doctorate, Yonath did postdoctoral research in the United States with F. Albert Cotton, one of her doctoral advisors, broadening her expertise in structural biology. Those formative years in Israel and the U.S. gave her the technical skills and theoretical knowledge she'd later need to pursue ribosomal structure determination.

Career

Early Research and the Ribosome Challenge

She returned to Israel after completing her postdoctoral work and joined the Weizmann Institute of Science faculty, where she'd spend most of her career. She also held a position at the University of Chicago. In the late 1970s and early 1980s, she began what would become her defining scientific endeavor: determining the ribosome's three-dimensional atomic structure through X-ray crystallography.

The ribosome is a massive molecular complex in all living cells. It translates genetic instructions from messenger RNA into proteins. Those proteins carry out virtually all cellular functions. Without ribosomes, organisms couldn't breathe, eat, or fight infection. Hemoglobin, digestion enzymes, and immune system components all depend on them. Understanding the ribosome's atomic structure was therefore one of the most important and challenging problems in structural biology.

Most scientists thought crystallizing ribosomes was impossible. Ribosomes are enormous by molecular standards. They're composed of hundreds of thousands of atoms. Their flexibility and complexity made crystallization extraordinarily difficult, and crystallization was essential for X-ray analysis. Yonath took on this challenge despite widespread skepticism in the scientific community. As the Nobel Prize organization noted, she "took on a challenge that others considered hopeless."

Development of Cryo Bio-Crystallography

One of her most important methodological contributions was developing and refining cryo bio-crystallography. The technique involves cooling biological crystals to extremely low temperatures to minimize radiation damage during X-ray data collection. This innovation made it possible to collect usable diffraction data from ribosomal crystals, which were especially sensitive to the intense X-ray beams required for structural analysis.

The technique came from an unexpected source. Yonath has recounted how observations of polar bears' ribosomes influenced her thinking. In hibernation, those ribosomes stayed organized, suggesting that cooling might preserve the structural integrity of ribosomal crystals during experimentation. This approach, combined with other technical innovations she developed, gradually made better-ordered ribosomal crystals possible and allowed collection of diffraction data with sufficient quality to begin solving the structure.

The work was painstaking and stretched across more than two decades. During this period, she faced not just scientific difficulties but personal setbacks too. A serious bicycle accident left her with a concussion. Instead of halting her research, the accident and recovery period inadvertently contributed fresh insights that moved her work forward.

Mapping the Ribosome Structure

Her research made use of advanced synchrotron radiation facilities, including those run by the United States Department of Energy, to collect the diffraction data needed for structural determination. These powerful X-ray sources were essential for resolving the positions of hundreds of thousands of atoms within the ribosomal complex.

By the late 1990s and early 2000s, she and her team at the Weizmann Institute achieved a series of breakthroughs. They produced increasingly detailed maps of both the large and small ribosomal subunits. The 2009 Nobel Prize in Chemistry cited the achievement of the "detailed mapping of the ribosome—the cell's own protein factory" as the basis for the award. The structural maps revealed how the ribosome reads mRNA and assembles amino acids into proteins, providing fundamental insights into one of the most essential biological processes.

The implications reached far beyond basic science into medicine. Many antibiotic drugs target the ribosome. By revealing the precise atomic structure, Yonath's work provided detailed understanding of how antibiotics bind to and inhibit bacterial ribosomes. That knowledge opened new avenues for designing more effective antibiotics. Growing antibiotic resistance made this development urgently needed.

Ongoing Research and Antibiotic Development

Following her Nobel Prize, she continued working at the Weizmann Institute, directing the Helen and Milton A. Kimmelman Center for Biomolecular Structure and Assembly. Her ongoing research exploits the structural knowledge of the ribosome to develop novel antibiotics that overcome bacterial resistance mechanisms. This work builds directly on the atomic-resolution maps of antibiotic binding sites that her earlier research produced.

She's been described as "one of the most prolific scientists in the world" for the breadth and impact of her contributions to structural biology and crystallography. Her research continues to ask fundamental questions about ribosome function and how its activity can be changed by drugs.

Contributions to Crystallography

Beyond her ribosome work, Yonath's career has substantially contributed to the broader crystallography field. In 2014, marking the International Year of Crystallography, she reflected on how the discipline had changed during her career and stressed the importance of crystallographic methods for understanding biological systems at the molecular level. Her cryo bio-crystallography techniques have applications far beyond ribosome research, influencing structural studies of many other large and fragile biological molecules.

Personal Life

Ada Yonath has one daughter, Hagit Yonath, who is also a scientist. She's spoken publicly about the challenges of balancing a demanding scientific career with family responsibilities, particularly as a single mother in a field dominated by men.

Her personality contrasts sharply with the stereotypical laboratory scientist. In her 2018 Chemistry World interview, she discussed her childhood curiosity and the unexpected paths that led to science, noting that she'd never specifically aimed at a scientific career. She's also spoken about her love of reading and imagination's role in scientific discovery.

She's known for her sense of humor and directness. In various public appearances following her Nobel Prize, she's discussed the personal costs of fame. Public lectures, interviews, and ceremonial obligations disrupted her research schedule.

Recognition

Ada Yonath has received numerous awards and honors throughout her career, reflecting the significance of her scientific contributions.

The Nobel Prize in Chemistry stands as her most prominent recognition. She won it in 2009 jointly with Venkatraman Ramakrishnan and Thomas A. Steitz "for studies of the structure and function of the ribosome." The prize recognized work spanning more than two decades that produced the first atomic-resolution structural maps of the ribosome.

The Israel Prize came in 2002, before the Nobel. It's one of the highest honors the State of Israel awards, recognizing her contributions to chemistry and scientific research. The Wolf Prize in Chemistry followed in 2007, another prestigious international science award.

In 2008, the Israeli Ministry of Foreign Affairs gave her a Life Work Prize for women in science, recognizing her sustained contributions to the field.

The World Cultural Council presented her with the Albert Einstein World Award of Science.

Numerous institutions worldwide have awarded her honorary degrees. The University of Warwick gave her one in 2015 in recognition of her scientific achievements. Carnegie Mellon University invited her in 2018 as a keynote speaker and honorary degree recipient, describing her as "one of the most prolific scientists in the world."

In 2014, Pope Francis appointed her to the Pontifical Academy of Sciences.

Legacy

Ada Yonath's work on the ribosome ranks among the landmark achievements of structural biology in the late twentieth and early twenty-first centuries. Her determination of the ribosome's atomic structure gave the scientific community an unprecedented understanding of how genetic information becomes the proteins that sustain life. That work has had lasting implications for both basic biological research and medical therapeutics, especially in antibiotic design.

Her cryo bio-crystallography techniques have transformed the broader structural biology field, making it possible to study large and fragile molecular complexes that were previously unreachable at high resolution. Laboratories around the world still use these methods, and they've contributed to structural studies of many biological systems beyond the ribosome.

As the first Israeli woman and the first woman from the Middle East to receive a Nobel Prize in the sciences, she's become a prominent figure in discussions about gender representation in science. Her career, marked by decades of persistence despite skepticism and technical obstacles, has served as an example for later generations of scientists. Her story tells it all: from Jerusalem's economic hardship to Stockholm's Nobel stage. It illustrates what sustained scientific inquiry can reveal about the fundamental processes of life.

She continues her research at the Weizmann Institute of Science, remaining active in investigating ribosome structure and developing new antibiotic strategies to combat drug-resistant bacteria.